James Cummings
2023
In 2023, James Cummings earned a total compensation of $1.2M as Chief Medical Officer at Biota Pharmaceuticals, a 39% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $128,128 |
|---|---|
| Option Awards | $428,840 |
| Salary | $454,667 |
| Stock Awards | $151,593 |
| Other | $11,706 |
| Total | $1,174,934 |
Cummings received $454.7K in salary, accounting for 39% of the total pay in 2023.
Cummings also received $128.1K in non-equity incentive plan, $428.8K in option awards, $151.6K in stock awards and $11.7K in other compensation.
Rankings
In 2023, James Cummings' compensation ranked 1,023rd out of 2,918 executives tracked by ExecPay. In other words, Cummings earned more than 64.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,023 out of 2,918 | 65th |
Division Manufacturing | 610 out of 1,608 | 62nd |
Major group Chemicals And Allied Products | 420 out of 901 | 53rd |
Industry group Drugs | 409 out of 864 | 53rd |
Industry Biological Products, Except Diagnostic Substances | 123 out of 211 | 42nd |
Source: SEC filing on April 29, 2024.
Cummings' colleagues
We found two more compensation records of executives who worked with James Cummings at Biota Pharmaceuticals in 2023.